[CRBP] Corbus Pharmaceuticals Holdings, Inc.

Overview

Type of security: Stock

Sector: Health Care

Industry: Major Pharmaceuticals

Market Capitalization: 127.66 M

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 8.55 Change: 0.2 (2.4%)
Ext. hours: Change: 0 (0%)

chart CRBP

Refresh chart

Fundamental Ratios
Shares Outstanding43.57 M EPS EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters Sales Growth - Q/Q P/E
P/E To EPS Growth P/S P/BV27.21 Price/Cash Per Share
Price/Free Cash Flow ROA-71.41% ROE-79.86% ROI
Current Ratio9.34 Quick Ratio Long Term Debt/Equity Debt Ratio0.12
Gross Margin Operating Margin Net Profit Margin Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities-10 K Cash From Investing Activities Cash From Operating Activities-1.28 M Gross Profit
Net Profit-1.54 M Operating Profit-1.54 M Total Assets5.25 M Total Current Assets5.18 M
Total Current Liabilities550 K Total Debt70 K Total Liabilities550 K Total Revenue
Technical Data
High 52 week8.95 Low 52 week4.65 Last close5.88 Last change2.26%
RSI41.5 Average true range0.32 Beta1.24 Volume250.54 K
Simple moving average 20 days-2% Simple moving average 50 days-10.22% Simple moving average 200 days-15.01%
Performance Data
Performance Week4.07% Performance Month-11.84% Performance Quart-21.7% Performance Half-23.44%
Performance Year26.45% Performance Year-to-date0.68% Volatility daily1.96% Volatility weekly4.39%
Volatility monthly8.99% Volatility yearly31.14% Relative Volume223.98% Average Volume719.37 K
New High New Low

News

2019-11-18 08:17:26 | Corbus Pharmaceuticals Completes Enrollment of Phase 2b Study of Lenabasum for Treatment of Cystic Fibrosis

2019-11-14 15:13:48 | Edited Transcript of CRBP earnings conference call or presentation 7-Nov-19 1:30pm GMT

2019-11-12 08:05:00 | Corbus Pharmaceuticals to Present at the Jefferies 2019 Global Healthcare Conference in London

2019-11-12 07:20:14 | We Think Corbus Pharmaceuticals Holdings NASDAQ:CRBP Can Afford To Drive Business Growth

2019-11-11 08:05:00 | Corbus Pharmaceuticals Updates Data from Lenabasum Open-Label Extension Studies in Systemic Sclerosis and Dermatomyositis at 2019 ACR Annual Meeting

2019-11-07 11:15:04 | Corbus Pharmaceuticals CRBP Reports Q3 Loss, Tops Revenue Estimates

2019-11-07 07:05:00 | Corbus Pharmaceuticals Reports 2019 Third Quarter Financial Results and Provides Clinical and Corporate Updates

2019-11-05 13:00:16 | 3 Under-the-Radar Stocks Top Insiders Are Snapping Up

2019-11-04 08:05:00 | Corbus Pharmaceuticals to Host Conference Call and Webcast to Discuss Third Quarter 2019 Operational and Financial Results on November 7, 2019

2019-11-01 12:08:28 | Were Hedge Funds Right About Selling Corbus Pharmaceuticals CRBP?

2019-10-13 10:06:29 | What Percentage Of Corbus Pharmaceuticals Holdings, Inc. NASDAQ:CRBP Shares Do Insiders Own?

2019-10-03 08:05:00 | Corbus Pharmaceuticals Announces Presentation of Three Abstracts and New Lenabasum Data at 2019 ACR Annual Meeting

2019-10-01 09:03:00 | Marijuana stocks are oversold — here’s how to know when to buy them

2019-09-13 07:21:17 | Health Check: How Prudently Does Corbus Pharmaceuticals Holdings NASDAQ:CRBP Use Debt?

2019-08-14 08:32:28 | Have Insiders Been Buying Corbus Pharmaceuticals Holdings, Inc. NASDAQ:CRBP Shares This Year?

2019-08-14 01:35:00 | Corbus Pharmaceuticals Holdings, Inc. CRBP Q2 2019 Earnings Call Transcript

2019-08-12 12:48:31 | Edited Transcript of CRBP earnings conference call or presentation 8-Aug-19 12:30pm GMT

2019-08-12 12:15:08 | Corbus Pharmaceuticals Holdings Inc CRBP COO Robert Paul Discordia Bought $87,900 of Shares

2019-08-08 15:00:00 | What You'll Want to Know About Corbus Pharmaceuticals' Q2 Results

2019-08-08 11:15:03 | Corbus Pharmaceuticals CRBP Q2 Earnings and Revenues Beat Estimates

2019-08-08 07:05:00 | Corbus Pharmaceuticals Reports 2019 Second Quarter Financial Results and Provides Clinical and Corporate Updates 

2019-07-12 13:32:04 | How Corbus Pharmaceuticals Holdings, Inc. NASDAQ:CRBP Can Impact Your Portfolio Volatility

2019-07-10 17:51:09 | Kadmon Initiates Dosing in Study for Systemic Sclerosis Drug

2019-07-03 17:00:00 | Horizons ETFs Rebalances Marijuana-Focused ETFs

2019-06-26 14:12:00 | Money flows in 17 popular marijuana stocks show fewer ‘short squeezes’

2019-06-17 08:05:10 | Corbus Pharmaceuticals to Host 2019 R&D Day in New York City

2019-06-12 08:05:00 | Lenabasum Open-Label Extension Data to be Presented at EULAR 2019 Continue to Show a Favorable Safety Profile and Improvement in Efficacy Outcomes in Systemic Sclerosis and Dermatomyositis Phase 2 Studies

2019-06-10 18:39:00 | Robbins Arroyo LLP: Corbus Pharmaceuticals Holdings, Inc. CRBP Sued for Misleading Shareholders

2019-05-29 10:39:55 | Understanding Medical Cannabis vs. Recreational Cannabis Stocks

2019-05-29 08:05:00 | Corbus Pharmaceuticals to Present at Two Upcoming Investor Conferences in June

2019-05-28 08:05:00 | Corbus Pharmaceuticals Announces Presentation of Six Abstracts at EULAR 2019 Annual Meeting

2019-05-24 09:16:15 | Does Corbus Pharmaceuticals Holdings, Inc.'s NASDAQ:CRBP CEO Pay Compare Well With Peers?

2019-05-23 08:17:00 | Is Corbus Pharmaceuticals a Buy Now?

2019-05-15 08:05:00 | Corbus Pharmaceuticals to Present at Two Upcoming Investor Conferences in May

2019-05-13 16:25:00 | SHAREHOLDER ALERT: CRBP FSNN MWA AAPL: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

2019-05-13 15:00:00 | CRBP, NIO & CORT Deadline Alert - Bronstein, Gewirtz & Grossman, LLC Class Action

2019-05-13 10:47:00 | FINAL DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Corbus Pharmaceuticals Holdings, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

2019-05-13 09:32:45 | The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of NIO, CRBP, ARA and NTNX

2019-05-10 15:55:00 | 3-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Corbus Pharmaceuticals Holdings, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

2019-05-10 15:00:00 | Bronstein, Gewirtz & Grossman, LLC Class Action Update: BPI, CRBP & NIO

2019-05-10 14:40:00 | FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of CRBP, ZGNX and BSX

2019-05-10 11:40:00 | DEADLINE MONDAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Corbus Pharmaceuticals Holdings, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

2019-05-10 10:33:00 | Bronstein, Gewirtz & Grossman, LLC Class Action: BPI, CRBP & NIO

2019-05-10 09:05:00 | SHAREHOLDER ALERT: CRBP MWA BSX: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

2019-05-09 17:59:54 | Edited Transcript of CRBP earnings conference call or presentation 9-May-19 12:30pm GMT

2019-05-09 16:52:18 | Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Corbus Pharmaceuticals Holdings, Inc.  

2019-05-09 16:20:00 | The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of USX, CRBP and MWA

2019-05-09 15:35:09 | SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Corbus Pharmaceuticals Holdings, Inc. of Class Action Lawsuit and Upcoming Deadline – CRBP

2019-05-09 15:00:00 | What You Need to Know About Corbus Pharmaceuticals' Q1 Earnings Update

2019-05-09 13:23:56 | Corbus Pharmaceuticals Holdings, Inc. CRBP Q1 2019 Earnings Call Transcript